Average Ratings 0 Ratings
Average Ratings 0 Ratings
Description
Graft AI is an enterprise platform that helps AI agents work inside legacy software by turning existing interfaces into reliable tools. The platform is designed for companies that rely on systems without modern APIs, including ERPs, mainframes, desktop applications, web portals, virtual desktops, internal tools, and file-based workflows. Graft observes real workflows and maps screens, inputs, transitions, rules, effects, and application states. It then compiles those workflows into stable typed contracts, adapters, policy boundaries, and conformance tests that agents can call through MCP-compatible tools. The platform verifies real source-system effects using independent evidence so the adapter cannot simply certify itself. Graft also enforces approvals, roles, permissions, boundaries, and least-privilege access so write actions stay governed. Every agent action is logged with context, making workflows auditable, traceable, and easier to review. The platform runs in the customer’s environment and states that customer data does not train its models. By combining interface intelligence, governed execution, verification, stable contracts, and auditability, Graft AI gives enterprises a practical bridge between existing software and modern AI agents.
Description
Pharmacists initiate a Comprehensive Medication Review at the start of programs to address issues related to medication nonadherence. Patients struggling to manage their diabetes face a significantly higher likelihood of severe complications, increased hospitalizations, and emergency room visits, which also leads to more costly associated health issues. Adhering to prescribed medications is crucial as it helps prevent the failure of transplanted organs, thereby avoiding challenging and costly complications like rejection episodes, infections, graft failure, and the need for retransplantation. emocha serves as the leading standard of care for numerous Tuberculosis programs nationwide. Additionally, emocha proves to be an effective resource for patients managing HIV and HCV medications. Furthermore, emocha aids employers and public health organizations across the nation by facilitating vaccination tracking, monitoring symptoms, conducting contact investigations and tracing, as well as providing a clinical triage service to ensure community safety and health. This multifaceted approach underscores the vital role of technology in enhancing patient care and public health initiatives.
API Access
Has API
No
API Access
Has API
No
Integrations
Model Context Protocol (MCP)
No
Pricing Details
No price information available.
Free Trial
No
Free Version
No
Pricing Details
No price information available.
Free Trial
No
Free Version
No
Deployment
Web-Based
Yes
On-Premises
No
iPhone App
No
iPad App
No
Android App
No
Windows
No
Mac
No
Linux
No
Chromebook
No
Deployment
Web-Based
Yes
On-Premises
No
iPhone App
No
iPad App
No
Android App
No
Windows
No
Mac
No
Linux
No
Chromebook
No
Customer Support
Business Hours
No
Live Rep (24/7)
Yes
Online Support
Yes
Customer Support
Business Hours
No
Live Rep (24/7)
No
Online Support
Yes
Types of Training
Training Docs
Yes
Webinars
No
Live Training (Online)
No
In Person
No
Types of Training
Training Docs
No
Webinars
No
Live Training (Online)
No
In Person
No
Vendor Details
Company Name
Graft AI
Website
graft.axcelner.com
Vendor Details
Company Name
emocha Health
Founded
2008
Country
United States
Website
emocha.com